Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

BMP6-induced modulation of the tumor micro-milieu.

Stieglitz D, Lamm S, Braig S, Feuerer L, Kuphal S, Dietrich P, Arndt S, Echtenacher B, Hellerbrand C, Karrer S, Bosserhoff AK.

Oncogene. 2019 Jan;38(5):609-621. doi: 10.1038/s41388-018-0475-x. Epub 2018 Aug 31.

PMID:
30171260
2.

TNF and regulatory T cells are critical for sepsis-induced suppression of T cells.

Stieglitz D, Schmid T, Chhabra NF, Echtenacher B, Männel DN, Mostböck S.

Immun Inflamm Dis. 2015 Aug 4;3(4):374-85. doi: 10.1002/iid3.75. eCollection 2015 Dec.

3.

High-Resolution Ultrasound Including Contrast-Enhanced Ultrasound (CEUS) for the Detection of Gas Formation during Aspergillus Fumigatus Infection in Mice.

Echtenacher B, Wege AK, Schardt K, Bitterer F, Gehmert S, Hoffmann P, Stroszczynski C, Jung EM.

Ultraschall Med. 2016 Jun;37(3):277-82. doi: 10.1055/s-0034-1398873. Epub 2015 Mar 5.

PMID:
25741669
4.
5.

TLR5 stop codon polymorphism is associated with invasive aspergillosis after allogeneic stem cell transplantation.

Grube M, Loeffler J, Mezger M, Krüger B, Echtenacher B, Hoffmann P, Edinger M, Einsele H, Andreesen R, Holler E.

Med Mycol. 2013 Nov;51(8):818-25. doi: 10.3109/13693786.2013.809630. Epub 2013 Jul 17.

PMID:
23862689
6.

Hypoferraemia during the early inflammatory response is dependent on tumour necrosis factor activity in a murine model of protracted peritonitis.

Schubert TE, Bosserhoff AK, Peyssonaux C, Echtenacher B, Knutson M, Hofstädter F, Männel DN.

Mol Med Rep. 2012 Oct;6(4):838-42. doi: 10.3892/mmr.2012.1004. Epub 2012 Jul 24.

PMID:
22842669
7.

ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression.

Hoetzenecker W, Echtenacher B, Guenova E, Hoetzenecker K, Woelbing F, Brück J, Teske A, Valtcheva N, Fuchs K, Kneilling M, Park JH, Kim KH, Kim KW, Hoffmann P, Krenn C, Hai T, Ghoreschi K, Biedermann T, Röcken M.

Nat Med. 2011 Dec 18;18(1):128-34. doi: 10.1038/nm.2557.

8.

Studies on galactofuranose-containing glycostructures of the pathogenic mold Aspergillus fumigatus.

Heesemann L, Kotz A, Echtenacher B, Broniszewska M, Routier F, Hoffmann P, Ebel F.

Int J Med Microbiol. 2011 Aug;301(6):523-30. doi: 10.1016/j.ijmm.2011.02.003. Epub 2011 May 20.

PMID:
21601522
9.

Genetic variation determines mast cell functions in experimental asthma.

Becker M, Reuter S, Friedrich P, Doener F, Michel A, Bopp T, Klein M, Schmitt E, Schild H, Radsak MP, Echtenacher B, Taube C, Stassen M.

J Immunol. 2011 Jun 15;186(12):7225-31. doi: 10.4049/jimmunol.1100676. Epub 2011 May 13.

10.

Approaching the secrets of N-glycosylation in Aspergillus fumigatus: characterization of the AfOch1 protein.

Kotz A, Wagener J, Engel J, Routier FH, Echtenacher B, Jacobsen I, Heesemann J, Ebel F.

PLoS One. 2010 Dec 29;5(12):e15729. doi: 10.1371/journal.pone.0015729.

11.

AfMkk2 is required for cell wall integrity signaling, adhesion, and full virulence of the human pathogen Aspergillus fumigatus.

Dirr F, Echtenacher B, Heesemann J, Hoffmann P, Ebel F, Wagener J.

Int J Med Microbiol. 2010 Nov;300(7):496-502. doi: 10.1016/j.ijmm.2010.03.001. Epub 2010 May 7.

PMID:
20452278
12.

The mitA gene of Aspergillus fumigatus is required for mannosylation of inositol-phosphorylceramide, but is dispensable for pathogenicity.

Kotz A, Wagener J, Engel J, Routier F, Echtenacher B, Pich A, Rohde M, Hoffmann P, Heesemann J, Ebel F.

Fungal Genet Biol. 2010 Feb;47(2):169-78. doi: 10.1016/j.fgb.2009.10.001. Epub 2009 Oct 12.

PMID:
19822220
13.

Murine models of anaemia of inflammation: extramedullary haematopoiesis represents a species specific difference to human anaemia of inflammation that can be eliminated by splenectomy.

Schubert TE, Obermaier F, Ugocsai P, Männel DN, Echtenacher B, Hofstädter F, Haerle P.

Int J Immunopathol Pharmacol. 2008 Jul-Sep;21(3):577-84.

PMID:
18831924
14.

The putative alpha-1,2-mannosyltransferase AfMnt1 of the opportunistic fungal pathogen Aspergillus fumigatus is required for cell wall stability and full virulence.

Wagener J, Echtenacher B, Rohde M, Kotz A, Krappmann S, Heesemann J, Ebel F.

Eukaryot Cell. 2008 Oct;7(10):1661-73. doi: 10.1128/EC.00221-08. Epub 2008 Aug 15.

15.

Properdin plays a protective role in polymicrobial septic peritonitis.

Stover CM, Luckett JC, Echtenacher B, Dupont A, Figgitt SE, Brown J, Männel DN, Schwaeble WJ.

J Immunol. 2008 Mar 1;180(5):3313-8.

16.

Investigations on the involvement of the lectin pathway of complement activation in anaphylaxis.

Windbichler M, Echtenacher B, Takahashi K, Ezekowitz RA, Schwaeble WJ, Jenseniuis JC, Männel DN.

Int Arch Allergy Immunol. 2006;141(1):11-23. Epub 2006 Jun 23.

PMID:
16804320
17.

Localization of the mouse defense lectin ficolin B in lysosomes of activated macrophages.

Runza VL, Hehlgans T, Echtenacher B, Zähringer U, Schwaeble WJ, Männel DN.

J Endotoxin Res. 2006;12(2):120-6.

PMID:
16690015
18.

Improved resistance to bacterial superinfection in mice by treatment with macrophage migration inhibitory factor.

Pollak N, Sterns T, Echtenacher B, Männel DN.

Infect Immun. 2005 Oct;73(10):6488-92.

19.

Failure of interferon-gamma and tumor necrosis factor in mediating anemia of chronic disease in a mouse model of protracted septic peritonitis.

Schubert TE, Echtenacher B, Hofstädter F, Männel DN.

Int J Mol Med. 2005 Oct;16(4):753-8.

PMID:
16142416
20.

Divergence of protection induced by bacterial products and sepsis-induced immune suppression.

Sterns T, Pollak N, Echtenacher B, Männel DN.

Infect Immun. 2005 Aug;73(8):4905-12.

21.

Involvement of the lectin pathway of complement activation in antimicrobial immune defense during experimental septic peritonitis.

Windbichler M, Echtenacher B, Hehlgans T, Jensenius JC, Schwaeble W, Männel DN.

Infect Immun. 2004 Sep;72(9):5247-52.

22.

Treatment of experimental sepsis-induced immunoparalysis with TNF.

Echtenacher B, Urbaschek R, Weigl K, Freudenberg MA, Männel DN.

Immunobiology. 2003;208(4):381-9.

PMID:
14748511
23.

TNF-independent development of transient anemia of chronic disease in a mouse model of protracted septic peritonitis.

Schubert T, Echtenacher B, Hofstädter F, Männel DN.

Lab Invest. 2003 Dec;83(12):1743-50.

24.
25.

Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis.

Echtenacher B, Freudenberg MA, Jack RS, Männel DN.

Infect Immun. 2001 Dec;69(12):7271-6.

26.

Functional role of melanoma inhibitory activity in regulating invasion and metastasis of malignant melanoma cells in vivo.

Bosserhoff AK, Echtenacher B, Hein R, Buettner R.

Melanoma Res. 2001 Aug;11(4):417-21.

PMID:
11479431
27.

Antimetastatic effect of CpG DNA mediated by type I IFN.

Hafner M, Zawatzky R, Hirtreiter C, Buurman WA, Echtenacher B, Hehlgans T, Männel DN.

Cancer Res. 2001 Jul 15;61(14):5523-8.

28.

Tumor necrosis factor-dependent adhesions as a major protective mechanism early in septic peritonitis in mice.

Echtenacher B, Weigl K, Lehn N, Männel DN.

Infect Immun. 2001 Jun;69(6):3550-5.

29.

The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle.

Benigni F, Atsumi T, Calandra T, Metz C, Echtenacher B, Peng T, Bucala R.

J Clin Invest. 2000 Nov;106(10):1291-300.

30.

VEGF/Flk-1 interaction, a requirement for malignant ascites recurrence.

Stoelcker B, Echtenacher B, Weich HA, Sztajer H, Hicklin DJ, Männel DN.

J Interferon Cytokine Res. 2000 May;20(5):511-7.

PMID:
10841080
31.

Protection from septic shock by neutralization of macrophage migration inhibitory factor.

Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, Hültner L, Heumann D, Männel D, Bucala R, Glauser MP.

Nat Med. 2000 Feb;6(2):164-70.

PMID:
10655104
32.

TNF in the inflammatory response.

Männel DN, Echtenacher B.

Chem Immunol. 2000;74:141-61. Review. No abstract available.

PMID:
10608086
33.

Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.

Hafner M, Falk W, Echtenacher B, Männel DN.

Eur Cytokine Netw. 1999 Dec;10(4):541-8.

34.

Migration of langerhans cells and dermal dendritic cells in skin organ cultures: augmentation by TNF-alpha and IL-1beta.

Stoitzner P, Zanella M, Ortner U, Lukas M, Tagwerker A, Janke K, Lutz MB, Schuler G, Echtenacher B, Ryffel B, Koch F, Romani N.

J Leukoc Biol. 1999 Sep;66(3):462-70.

PMID:
10496317
35.

Acute systemic reaction and lung alterations induced by an antiplatelet integrin gpIIb/IIIa antibody in mice.

Nieswandt B, Echtenacher B, Wachs FP, Schröder J, Gessner JE, Schmidt RE, Grau GE, Männel DN.

Blood. 1999 Jul 15;94(2):684-93.

PMID:
10397735
36.

Lysis of tumor cells by natural killer cells in mice is impeded by platelets.

Nieswandt B, Hafner M, Echtenacher B, Männel DN.

Cancer Res. 1999 Mar 15;59(6):1295-300.

37.

The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells.

Maurer M, Echtenacher B, Hültner L, Kollias G, Männel DN, Langley KE, Galli SJ.

J Exp Med. 1998 Dec 21;188(12):2343-8.

38.

Protective effect of a single interleukin-12 (IL-12) predose against the toxicity of subsequent chronic IL-12 in mice: role of cytokines and glucocorticoids.

Sacco S, Heremans H, Echtenacher B, Buurman WA, Amraoui Z, Goldman M, Ghezzi P.

Blood. 1997 Dec 1;90(11):4473-9.

PMID:
9373257
39.

Generation of a mouse tumor necrosis factor mutant with antiperitonitis and desensitization activities comparable to those of the wild type but with reduced systemic toxicity.

Lucas R, Echtenacher B, Sablon E, Juillard P, Magez S, Lou J, Donati Y, Bosman F, Van de Voorde A, Fransen L, Männel DN, Grau GE, de Baetselier P.

Infect Immun. 1997 Jun;65(6):2006-10.

40.

Carrageenan-induced acute inflammation in the mouse air pouch synovial model. Role of tumour necrosis factor.

Romano M, Faggioni R, Sironi M, Sacco S, Echtenacher B, Di Santo E, Salmona M, Ghezzi P.

Mediators Inflamm. 1997;6(1):32-8.

41.

Critical protective role of mast cell-derived tumour necrosis factor in bacterial infection.

Männel DN, Hültner L, Echtenacher B.

Res Immunol. 1996 Oct-Dec;147(8-9):491-3. Review. No abstract available.

PMID:
9127878
42.

Critical protective role of mast cells in a model of acute septic peritonitis.

Echtenacher B, Männel DN, Hültner L.

Nature. 1996 May 2;381(6577):75-7.

PMID:
8609992
43.

[Immunologic aspects of normal and disordered wound healing].

Echtenacher B.

Zentralbl Chir. 1996;121 Suppl:18-9. German. No abstract available.

PMID:
8967225
44.

Effect of gene-targeted mutation in TNF receptor (p55) on contact hypersensitivity and ultraviolet B-induced immunosuppression.

Kondo S, Wang B, Fujisawa H, Shivji GM, Echtenacher B, Mak TW, Sauder DN.

J Immunol. 1995 Oct 15;155(8):3801-5.

PMID:
7561085
45.

Cellular and molecular mechanisms of TNF protection in septic peritonitis.

Echtenacher B, Hültner L, Männel DN.

J Inflamm. 1995-1996;47(1-2):85-9. Review.

PMID:
8913934
46.

Protective effect of chlorpromazine on TNF-mediated hapten-induced irritant reaction.

Erroi A, Fantuzzi G, Demitri MT, Echtenacher B, Gnocchi P, Isetta A, Ghezzi P.

Eur Cytokine Netw. 1995 Jan-Feb;6(1):55-7.

PMID:
7795176
47.

Role of xanthine oxidase and reactive oxygen intermediates in LPS- and TNF-induced pulmonary edema.

Faggioni R, Gatti S, Demitri MT, Delgado R, Echtenacher B, Gnocchi P, Heremans H, Ghezzi P.

J Lab Clin Med. 1994 Mar;123(3):394-9.

PMID:
8133151
48.

Enhancement of experimental metastasis by tumor necrosis factor.

Orosz P, Echtenacher B, Falk W, Rüschoff J, Weber D, Männel DN.

J Exp Med. 1993 May 1;177(5):1391-8.

49.
50.

T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor.

Miethke T, Wahl C, Heeg K, Echtenacher B, Krammer PH, Wagner H.

J Exp Med. 1992 Jan 1;175(1):91-8.

Supplemental Content

Loading ...
Support Center